S+N being bought

Quote



anonymous said:
Our leaders and some analysts think we are “turning it around.” We have subpar products. Engage was a disaster and great job on diligence bald headed r&d idiot. Namal hated him.

I wonder if our 12 pt plan will make up for our shit products and silly robotics. Skip was right we needed a robotic arm.
Click to expand...
Skip didn’t come up with need for robotic arm, Namal did and sent Skip to Munich to close the deal with Brainlab. They already owned 1/3rd of the company doing the table mounted arm and purchased the other 2/3 when they realized our intense interest.

That $110M deal happened in 2019 and was worthless by 2021. Then the $240M deal for Integra in ‘21 by Skip with almost no due diligence which was written down by $100M in ‘22. The shoulder system was supposed to be “ready to go” which took two more years to get to market. And Engage, the next screw up which was $260M only to be recalled and shelved almost immediately. That’s $610M in failed M&A deals in 4 years and that’s not even talking about the $300M+ Cartiheal deal for buying a lifetime supply of coral reef
 


Investors are PISSED! CFO tired of it all my guess. Sounds like they packing ortho up to sell and potentially keeping only Woundcare around with the SN name, back to our roots. Taking care of civil war victims lol.
 






Ortho has its own challenges, I would argue ortho makes the most sense to spin off and SN get back to its roots. Let’s see what the next investors meeting reveals… will be telling.
 




anonymous said:
When is the next investors meeting?
Click to expand...
They have been doing it on their own, calling out SN for cooking the books. Research firm Dragoneye has called out SN for cooking the books recently. Investors not happy they got involved.
“Dragoneye's research suggests that Smith & Nephew may have deferred amortization costs and underreported inventory write-offs, boosting their profit margin by 1.7 percentage points.“
Also last year remember SN CEO wanted a 30% raise. They layed off important people to give that money to the ceo who is destroying smith and nephew. Honestly this is a money grab for this leadership, they need to be fired asap to salvage anything SN has left. Sad sad times. Never thought SN would become this, a disaster inside and out.

Smith & Nephew investors urged to oppose ‘excessive’ pay rise for boss​

FTSE 100 group wants to raise US-based Deepak Nath’s pay by almost 30% to a maximum of $11.8mn
 








Look at the stock price since the 2024 year end announcement late February. Stock rose not even to October price when they lowered the yearly projection. They met the lowered number, just barely and by laying off a bunch of people and cancelling projects. Down days are large volume, up days are low volume. The annual report brags that 60% of sales come from products released in the last 5 years, there is nothing to sustain this. DragonEye is right.
 


Last solid product released was OR30 and the inventory levels are not where they need to be. Good luck with catalyst. The market will have moved to a new stem design by the time half the field gets it.
 


What are we going to sell in Ortho in the next few years? Outdated implants installed with a burring robot? I called a friend in product development to ask a tech question. He said they laid off the directors and some engineers in hips, shoulders, ankles, and ex-fix. No new projects in any of these groups. It's all about knees nails and plates.
 


anonymous said:
What are we going to sell in Ortho in the next few years? Outdated implants installed with a burring robot? I called a friend in product development to ask a tech question. He said they laid off the directors and some engineers in hips, shoulders, ankles, and ex-fix. No new projects in any of these groups. It's all about knees nails and plates.
Click to expand...
We don’t innovate, we haven’t for years now. We buy companies and shelve the products for market share. Duh.
 





Write your reply...
Top Bottom
Back
Quote